最新消息

News & Message

:::
首頁/
最新消息/
期刊論文/
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer

最新消息

2026/2/3

INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer

INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer

回上頁

相關文章

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study
側邊開關圖示開關
首頁 Facebook Instagram 體系醫院 中國醫點通
▲至頂
分享到： 文心一言 百度知道 支付宝 微博 QQ空间 QQ 豆瓣 知乎 CSDN 博客园 简书 百家号 搜狐号 网易号 腾讯
百度 搜狗 360搜索 意甲-佳夫乌龙亚伯拉罕破门 米兰连扳两球2-2佛罗伦萨 中粮资本A股发布声明 买金饰可优先考虑小克重 ins新乐园烟头事件当事人再回应质疑 清明假期各地祭扫活动平稳有序 透视出行消费亮点 
      <code id='5084c'></code><style id='4e509'></style>
      • <acronym id='533c0'></acronym>
      <center id='fcb4e'><center id='471d5'><tfoot id='b00bf'></tfoot></center><abbr id='46f62'><dir id='42b11'><tfoot id='81718'></tfoot><noframes id='9fd66'>
      • <optgroup id='cbc51'><strike id='9f535'><sup id='82fb7'></sup></strike><code id='e4017'></code></optgroup>
        5. <b id='be983'><label id='8cbac'><select id='a5ec3'><dt id='c7a27'><span id='29086'></span></dt></select></label></b><u id='93a16'></u>
          <i id='03141'><strike id='f668b'><tt id='2fb72'><pre id='f99e7'></pre></tt></strike></i>